Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More | Frank Vinluan | 10/09/20 | National |
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More | Frank Vinluan | 03/27/20 | National |
CytomX Lands $80M to Kick Off Cancer Drug R&D Pact With Astellas | Frank Vinluan | 03/24/20 | San Francisco |
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More | Frank Vinluan | 10/18/19 | National |
Bio Roundup: Trumpcare Wavers, Amgen Courts Payers, Critics Circle PTC | Ben Fidler | 03/24/17 | National |
First Trial Underway, CytomX Gets $200M More In Expanded Bristol Pact | Ben Fidler | 03/20/17 | San Francisco |
Cleave Bio Gets $37M From Celgene, Others For Clinical Push | David Holley | 08/08/16 | San Francisco |
West Coast Bio Roundup: Prince, Theranos, Second Genome, CytomX & More | Alex Lash | 04/22/16 | San Francisco |
West Coast Biotech Roundup: StemCells, Five Prime, Qualcomm & More | Alex Lash | 01/22/16 | San Francisco |
West Coast Biotech Roundup: KaloBios, Atreca, Acadia, Twist & More | Alex Lash | 11/06/15 | San Francisco |
Despite Sanofi’s Help, MyoKardia Prices IPO Below Expectations | Ben Fidler | 10/29/15 | San Francisco |
Gene Therapy Startup Dimension Cuts Price But Bags $72M in IPO | Ben Fidler | 10/21/15 | Boston |
Voyager Charts an IPO Course Amid Choppy Biotech Waters | Ben Fidler | 10/11/15 | Boston |
No Drug Yet In Clinic, But CytomX Raises $80M In Discounted IPO | Alex Lash | 10/08/15 | San Francisco |
CytomX Therapeutics Receives $80,000,000 New Funding | VentureDeal | 10/08/15 | San Francisco |
Selecta, Eyeing IPO, Brings Sanofi, Crossovers Aboard For $38M Round | Ben Fidler | 09/08/15 | Boston |
West Coast Biotech Roundup: Amgen, Grizzlies, Topol, Faraday & More | Alex Lash | 09/03/15 | San Francisco |
West Coast Biotech Roundup: Avalanche, CytomX, BioMarin, Dubs & More | Alex Lash | 06/19/15 | San Francisco |
CytomX Therapeutics Receives $70,000,000 Series D Financing | VentureDeal | 06/17/15 | San Francisco |
West Coast Biotech Roundup: Hep C, 23andMe, Kite, Cash, Isis & More | Alex Lash | 01/08/15 | San Francisco |
One Week Into The New Year, Five Biotechs Reel in $220M Venture Cash | Alex Lash | 01/08/15 | National |
CytomX Therapeutics Receives $20,000,000 Series C Financing | VentureDeal | 01/06/15 | San Francisco |
CytomX Snags $25M From Pfizer to Make Souped-Up Antibodies | Luke Timmerman | 06/06/13 | San Francisco |
CytomX Therapeutics Adds $11M For Antibody Drugs | Luke Timmerman | 07/31/12 | San Francisco |
CytomX Therapeutics Lands $31,000,000 Series B Financing | VentureDeal | 07/31/12 | San Francisco |
Igenica Pulls in $33M to Fight Cancer With Antibodies | Luke Timmerman | 06/12/12 | San Francisco |
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies | Luke Timmerman | 05/16/12 | National |
CytomX Therapeutics Seeks to One-Up Lilly, Amgen Cancer Drugs | Luke Timmerman | 03/02/12 | San Francisco |
Cleave Biosciences Nabs $42M, Veteran Execs, to Chase Personalized Cancer Therapies | Luke Timmerman | 10/11/11 | San Francisco |
Zymeworks Snags $187M Deal With Merck to Discover Multi-Pronged Antibodies | Luke Timmerman | 08/29/11 | Seattle |